Tagged With Johnson & Johnson

Johnson & Johnson's net earnings dropped 14% in the first-quarter

Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential

Johnson & Johnson is being investigated by the SEC over fears its baby powder may cause cancer — here's how worried you should be

Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety

A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval

A fresh crop of promising drugs is poised to change the way depression is treated for the first time in decades. Here are the ones to watch in 2019.

Johnson & Johnson tumbles after report says it knew for decades that its baby powder contained asbestos

Almost $40 billion has been erased from Johnson & Johnson's market value, but JPMorgan says the selling is overdone

Canada warns talcum powder poses a risk of ovarian cancer after $4.69 billion product defect case

Take a look inside Johnson & Johnson's new startup incubator in NYC's SoHo neighbourhood, that feels more like a rustic-chic coffee shop with jewel-toned couches

Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called 'the most important discovery in half a century'

A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift

There's soaring interest in CBD, the marijuana compound in a drug that could be the first to win FDA approval -- here's what it does

Ketamine could become the first new depression drug in more than 30 years

The science-backed 7-minute fitness routine is a great way to get in shape

I tried the science-backed 7-minute fitness routine and was blown away by how well it works

DIGITAL HEALTH BRIEFING: Johnson & Johnson introduces healthcare platform -- NIH will give out 10,000 Fitbit devices -- Hasbro, Brown develop robotic companions

How Elon Musk, Jeff Bezos, and 19 other famous CEOs are doing, according to their employees

Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine

Pfizer is taking its fight with J&J over a blockbuster drug to court